Commerce Bank boosted its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 17.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,139 shares of the medical instruments supplier's stock after purchasing an additional 475 shares during the period. Commerce Bank's holdings in Mettler-Toledo International were worth $4,708,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC raised its stake in shares of Mettler-Toledo International by 8.0% during the first quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier's stock worth $117,000 after buying an additional 7 shares during the last quarter. UMB Bank n.a. raised its position in shares of Mettler-Toledo International by 6.6% during the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier's stock worth $158,000 after purchasing an additional 7 shares during the period. Bellevue Group AG lifted its stake in Mettler-Toledo International by 32.0% in the first quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier's stock valued at $44,000 after buying an additional 8 shares in the last quarter. Massmutual Trust Co. FSB ADV boosted its stake in Mettler-Toledo International by 7.2% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier's stock worth $166,000 after purchasing an additional 8 shares during the period. Finally, DT Investment Partners LLC grew its holdings in shares of Mettler-Toledo International by 13.3% during the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier's stock worth $102,000 after buying an additional 8 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have commented on MTD. Stifel Nicolaus cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating for the company in a research note on Monday, November 11th. Wells Fargo & Company reduced their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating for the company in a research note on Monday, November 11th. JPMorgan Chase & Co. increased their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a "neutral" rating in a research report on Monday, August 5th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 1st. Finally, Robert W. Baird lowered their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a report on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International presently has an average rating of "Hold" and an average target price of $1,338.75.
Get Our Latest Report on MTD
In other news, Director Elisha W. Finney sold 76 shares of the company's stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares of the company's stock, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.94% of the company's stock.
Mettler-Toledo International stock opened at $1,217.97 on Friday. The firm has a 50 day moving average price of $1,361.85 and a 200-day moving average price of $1,397.91. Mettler-Toledo International Inc. has a twelve month low of $1,059.08 and a twelve month high of $1,546.93. The company has a market capitalization of $25.70 billion, a P/E ratio of 32.84, a P/E/G ratio of 3.95 and a beta of 1.16.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Equities analysts expect that Mettler-Toledo International Inc. will post 40.39 EPS for the current fiscal year.
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.